Skip to main content
. Author manuscript; available in PMC: 2023 Oct 1.
Published in final edited form as: J Invest Dermatol. 2022 Apr 4;142(10):2773–2782.e16. doi: 10.1016/j.jid.2022.03.017

Figure 5: Gene family and pathway enrichment in HS vs. SCC.

Figure 5:

Volcano plots show differentially abundant pathways (a) and gene families (b) identified in matched HS and SCC samples through paired Wilcoxon test with FDR-corrected p-values (q-value). For legibility, only a subset of gene families is labelled in the plot. For b, the comprehensive list of all differentially abundant gene families is listed in Table S5. For pathways and gene families, a q-value <0.05 with a log2-fold change (Log2FC) of 2 were deemed significant (green). Data points to the far right or far left indicate zero abundance in HS or SCC, respectively.